GADEWAR, M., & LAL, B. (2022). MOLECULAR DOCKING AND SCREENING OF DRUGS FOR 6LU7 PROTEASE INHIBITOR AS A POTENTIAL TARGET FOR COVID-19. International Journal of Applied Pharmaceutics, 14(1), 100–105. https://doi.org/10.22159/ijap.2022v14i1.43132